azelaic acid

(redirected from Finacea)
Also found in: Dictionary, Encyclopedia.
Related to Finacea: Azelaic acid, rosacea

azelaic acid

 [az″ĕ-la´ik]
a dicarboxylic acid occurring in whole grains and animal products; it has antibacterial effects on both aerobic and anaerobic organisms, particularly Propionibacterium acnes and Staphylococcus epidermidis, normalizes keratinization, and has a cytotoxic effect on malignant or hyperactive melanocytes; applied topically in the treatment of acne vulgaris.

azelaic acid

/az·e·la·ic ac·id/ (az″ĕ-la´ik) a topical antibacterial used in the treatment of acne vulgaris.

azelaic acid

[az′ĕ-la′ik]
a dicarboxylic acid occurring in whole grains and animal products. It has antibacterial effects on both aerobic and anaerobic organisms, particularly Propionibacterium acnes and Staphylococcus epidermidis; normalizes keratinization; and has a cytotoxic effect on malignant or hyperactive melanocytes. It is applied topically in the treatment of acne vulgaris.

azelaic acid

A substance first identified in rancid oleic acid which interferes with anerobic glycolysis and mitochondrial activity. Azelaic acid has antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis, possibly by inhibiting microbial protein synthesis.

Dermatology
AZELEX Cream is indicated for the topical treatment of mild to moderate inflammatory acne vulgaris; another formulation, Finacea, is a topical gel used to manage inflammatory papules and pustules of mild to moderate rosacea.

Fringe oncology
Some anecdotal data suggest possible efficacy of alelaic acid in managing lentigo maligna, a form of melanoma.

azelaic acid

An antibacterial drug used externally in the form of a skin cream. A brand name is Skinoren.

azelaic acid (az´əla´ik),

n brand name: Azelex;
drug class: a naturally occurring straight-chain dicarboxylic acid;
action: has antimicrobial activity against
P. acnes and
S. epidermidis; use: topical therapy of mild-tomoderate inflammatory acne vulgaris.
References in periodicals archive ?
The company added that Finacea Foam was developed as part of a research and development collaboration with Foamix Pharmaceuticals (NasdaqGM:FOMX) utilising Foamix's proprietary foam technology platform.
Under the license agreement between the two companies, Foamix is entitled to royalties and certain milestone payments upon commercialisation of Finacea Foam.
Beginning September 2015, Finacea Foam will be marketed in the US by Bayer HealthCare and will be available by prescription.
pruritis, burning or stinging) may occur during use of Finacea, usually in the first few weeks of treatment.
Patients Bothered by Treatment-Related Stinging and Burning MetroGel 26% Finacea 47% Note: Based on a study of 180 patients.
pruritis, burning or stinging) may occur during use with Finacea, usually during the first few weeks of treatment.
Finacea (rhymes with rosacea) is expected to be available early this year.
Although Finacea is a lower concentration than azelaic acid cream, Dr.
In addition to the website, Glow Worm developed a new Finacea consumer brand strategy, an integrated CRM email newsletter campaign, a patient starter packet and a printed brochure.
Unlike some topical medications whose effectiveness levels off after eight weeks, in a medical trial, rosacea sufferers using Finacea experienced a continuous decline in symptoms throughout 12 weeks of treatment.
We are excited about the opportunity that FINACEA brings to the market.
The introduction of FINACEA brings to this important market an exciting new therapy for the treatment of rosacea," said Bill Humphries, Allergan's Vice President U.